Lipocine Inc.
LPCN- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001535955
No open-market purchases or sales by Lipocine Inc. insiders were filed in the last 90 days; 36 institutions reported holding it in 13F filings for Q2 2026, worth $7.63M in total; no superinvestor holds it.
Q3 2021 vs. Q2 2021
How the institutions holding Lipocine Inc. changed between Q2 2021 and Q3 2021.
All holders in Q3 2021All holders in Q2 2021
| Measure | Q2 2021 | Q3 2021 | Change |
|---|---|---|---|
| Holders | 33 | 38 | +5 |
| Shares | 9.13M | 9.19M | +59.3K (+0.7%) |
| Value | $12.8M | $10.0M | −$2.76M (−21.6%) |
New holders (7)
Institutions that held Lipocine Inc. at the end of Q3 2021 but not at the end of Q2 2021.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Citadel Advisors LLC | 55,620 | $61.0K | 0.00% |
| Susquehanna International Group, LLP | 39,697 | $43.0K | 0.00% |
| Jane Street Group, LLC | 37,482 | $41.0K | 0.00% |
| Virtu Financial LLC | 30,069 | $33.0K | 0.00% |
| Qube Research & Technologies Ltd | 24,075 | $26.0K | 0.00% |
| ExodusPoint Capital Management, LP | 22,667 | $25.0K | 0.00% |
| Tower Research Capital LLC (TRC) | 7,568 | $8.00K | 0.00% |
Sold out (2)
Institutions that held Lipocine Inc. at the end of Q2 2021 and filed for Q3 2021 without it.
| Institution | Shares, Q2 2021 | Value, Q2 2021 |
|---|---|---|
| Pura Vida Investments, LLC | 54,738 | $77.0K |
| Charles Schwab Investment Management Inc | 36,595 | $52.0K |